These are illustrative figures derived from community formulation reports, not a clinical protocol
These are all part of a class of drugs called GLP-1 agonists, and they're making waves in how we manage conditions like type 2 diabetes and obesity
GSTs conjugate 4HNE to GSH, and the corresponding glutathionyl-4-HNE (GS-HNE) is actively transported out of cells via RLIP76, a multifunctional membrane transporter for GSH-conjugated compounds, and/or MRPs (multidrug-resistance proteins
The results showed that compared to placebo, GLP-1 receptor agonists reduced the risk of kidney failure by 16% and the worsening of kidney function by 22% (defined by a drop in estimated glomerular filtration rate a measure of how much blood the kidneys filter clean every minute of at least 50%)
Sirtuins are like a cellular repair crew
What are copper peptides good for